Ernexa Therapeutics Inc. (ERNA) vs 60 Degrees Pharmaceuticals, Inc. (SXTP)
A side-by-side comparison of Ernexa Therapeutics Inc. and 60 Degrees Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ERNA
Ernexa Therapeutics Inc.
$2.24HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SXTP
60 Degrees Pharmaceuticals, Inc.
$1.11HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — ERNA vs SXTP
growth of $100 · dividends reinvested · last 3yERNA -99.7% (-85.3%/yr)SXTP -99.9% (-89.1%/yr)ERNA compounded faster over this window
ERNA SXTP
ERNA vs SXTP: by the numbers
- •SXTP is the larger company ($4M vs $4M market cap).
- •Both run net losses; ERNA's is the smaller (0.00% vs -730.23% net margin).
Metrics side by side
Valuation
| Metric | ERNA | SXTP |
|---|---|---|
| P/S ratio | N/A | 3.51 |
| P/B ratio | 1.14 | N/A |
Profitability
| Metric | ERNA | SXTP |
|---|---|---|
| Gross margin | 0.00% | 19.42% |
| Operating margin | 0.00% | -774.90% |
| Net margin | 0.00% | -730.23% |
| ROE | -383.03% | -310.33% |
| ROIC | -346.94% | -321.28% |
Growth (annualized)
| Metric | ERNA | SXTP |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -14.35% |
| Total return CAGR (5Y) | -86.83% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.